| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.11 | 8e-05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |